home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Adapting IRT Resupply Algorithms to Balance Risk and Cost

 
  October 29, 2024  
     
 
Xtalks, Online
2024-11-19


In clinical trials, managing investigational medicinal product (IMP) supply is critical to ensuring trial success. The interactive response technology (IRT) site resupply algorithm is a key component of this process, designed to balance two major considerations: risk (the security of IMP supply) and cost (associated with IMP waste and distribution).

While traditional IRT platforms generally rely on a standard resupply algorithm that combines buffer stock levels with predictable demand forecasting, this approach may not be optimal for every clinical trial. Each trial has a unique set of factors influencing the optimal resupply strategy, including trial design, patient enrollment rates, geographic distribution and supply chain complexities.

Advanced IRT and randomization and trial supply management (RTSM) platforms offer a more flexible solution by supporting a portfolio of resupply algorithms, allowing sponsors and vendors to collaborate in identifying the algorithm that best suits the needs of a particular trial. By leveraging the sponsor’s deep knowledge of the trial and the RTSM vendor’s expertise in resupply capabilities, the ideal balance between risk and cost can be achieved. This collaboration is essential to tailoring the resupply strategy to the specific demands of each study, reducing IMP waste, lowering distribution costs and maintaining a secure and efficient supply chain.

This session will explore the benefits of using advanced RTSM systems to customize site resupply algorithms, highlighting the critical role of sponsor-vendor collaboration. Attendees will gain insights into how different resupply strategies can impact trial outcomes and learn best practices for implementing a more flexible and efficient approach to RTSM site resupply management.

Register for this webinar to learn how to optimize a clinical trial’s resupply strategy and improve overall trial efficiency.

Keywords: Interactive Response Technology, Other Software, CT Logistics, Supply Chain/Logistics, Demand Planning, Clinical Trial Supply Chain, Interactive Response Technologies, Clinical IRT, Clinical Trial Supply Management, Drug Development, RTSM, IRT, Drug Supply, Clinical Supply Chain, Clinical Supply, Supply Management System, Clinical Research
 
 
Organized by: Xtalks
Invited Speakers: Benjamin Etschmann, Senior Forecasting Services Lead, 4G Clinical
Conor Hayes, Client Services Lead, 4G Clinical
Buz Hillman, Associate Director, Strategic Management and Systems Discovery, Product Development & Supply, Johnson and Johnson
(Moderator) Libbi Rickenbacher, Sr. Director of Product Strategy and Partnerships, 4G Clinical
 
Deadline for Abstracts: 2024-11-19
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.